crc-23-0075_fig1.png (100.08 kB)

FIGURE 1 from Prediagnostic CT or MRI Utilization and Outcomes in Hepatocellular Carcinoma: SEER-Medicare Database Analysis

figure

posted on 2023-05-16, 14:20 authored by Mohammad A. Karim, Amit G. Singal, Hye Chung Kum, Yi-Te Lee, Sulki Park, Nicole E. Rich, Mazen Noureddin, Ju Dong Yang

Distribution of PTC with ultrasound (US) or CT/MRI for patients with HCC. A, Distribution of PTC with ultrasound for all the patients with HCC in the study. B, Distribution of PTC with CT/MRI for all the patients with HCC in the study. CT, computed tomography; HBV, hepatitis B virus; HCC, hepatocellular carcinoma; MRI, magnetic resonance imaging; PTC, proportion of time covered.

Funding

Cancer Prevention and Research Institute of Texas (CPRIT)

HHS | National Institutes of Health (NIH)

Population Informatics Lab at Texas A&M University

Texas Virtual Data Library at Texas A&M University

American College of Gastroenterology (ACG)

DOD | USA | MEDCOM | CDMRP | DOD Peer Reviewed Cancer Research Program (PRCRP)

History

ARTICLE ABSTRACT

Our population-based study using SEER-Medicare database demonstrated that proportion of time covered by abdominal imaging was associated with improved survival in patients with HCC, with potential greater benefit using CT/MRI. The results suggest that CT/MRI surveillance may have potential survival benefit compared with ultrasound surveillance in high-risk patients for HCC. A larger prospective study should be conducted for external validation.

Usage metrics

Keywords

Gastrointestinal Cancers Liver cancer Clinical Imaging Descriptive Studies Imaging Magnetic resonance imaging (MRI)X-ray computed tomography (CT)Cancer Interception Cancer surveillance and screening

Licence

CC BY

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM